A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome

Clinical trial NCT05282446 · COMPLETED

Trial details

NCT number: NCT05282446
Sponsor: Inversago Pharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metabolic Syndrome

Start date: 2022-03-01
Primary completion: 2022-09-11
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.